AIM ImmunoTech Receives Erasmus Medical Center Ethics Board
OCALA, Fla., Jan. 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has...
Processa Pharmaceuticals Announces Pricing of $7.0 Million
HANOVER, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused...
BrightSpring Celebrates First Day of Trading on Nasdaq
LOUISVILLE, Ky., Jan. 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) today marked its first...
Pending Home Sales Climbed 8.3% in December
WASHINGTON, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Key Highlights Pending home sales increased 8.3% in December.Month over month,...
Sound Group Inc. (Formerly LIZHI INC.) Announces Corporate
SINGAPORE, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Sound Group Inc., formerly known as LIZHI INC. (“Sound Group” or the “Company”), a global...
YanGuFang Announces Receipt of Nasdaq Notice of Deficiency
SHANGHAI, China, Jan. 25, 2024 (GLOBE NEWSWIRE) -- YanGuFang International Group Co., Ltd. (Nasdaq: YGF) (“YanGuFang” or the “Company”), a health food...
The Inverse Cramer Tracker ETF to be Closed and Liquidated
GREENWICH, Conn., Jan. 25, 2024 (GLOBE NEWSWIRE) -- via IBN -- The Board of Trustees of the Northern Lights Fund Trust IV...
Roper Technologies to acquire Procare Solutions
SARASOTA, Fla., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) today announced that it has reached a definitive agreement...
ACM Research’s Operating Subsidiary ACM Research (Shanghai)
FREMONT, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for...
Ocuphire Pharma Reports Inducement Grants Under Nasdaq
FARMINGTON HILLS, Mich., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing...
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule
STAMFORD, Conn., Jan. 24, 2024 (GLOBE NEWSWIRE) -- GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today...
PharmAla receives new “MDXXF” ticker from FINRA for OTCQB
VANCOUVER, British Columbia, Jan. 24, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology...
